At Apogee Therapeutics, I built a global Medical Affairs organization and lead enterprise medical strategy across the immunology development portfolio. I align evidence generation, publications, scientific exchange, clinical development, and commercialization priorities.
Previously, I led Medical Affairs at Cara Therapeutics through the global launch of Korsuva/Kapruvia and directed global dermatology strategy for Otezla at Celgene. Across biotechnology and pharmaceutical organizations, I’ve built teams, advanced RWE and HEOR programs, guided clinical development, and partnered with KOLs, regulators, and cross-functional leaders.
